BUNGE GLOBAL SA (BG)
(Delayed Data from NYSE)
$100.32 USD
-0.31 (-0.31%)
Updated Aug 27, 2024 04:00 PM ET
3-Hold of 5 3
A Value D Growth C Momentum B VGM
Price, Consensus and EPS Surprise
BG 100.32 -0.31(-0.31%)
Will BG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BG based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BG
5 Broker-Favored Stocks Worth a Look in the Current Scenario
Repsol (REPYY) Taps Honeywell to Boost Biofuels Production
BG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Arcadia Biosciences (RKDA) Q2 Earnings Miss, Increase Y/Y
Bunge Global (BG) Lags Q2 Earnings and Revenue Estimates
Zacks Industry Outlook Highlights Bunge, West Fraser Timber, GrowGeneration and Hydrofarm
Other News for BG
Sustainable Agriculture: The Growing Need for Biotech Innovations in the World's Food Supplies
Bunge goes ex dividend today
BG April 2025 Options Begin Trading
FXG: Consumer Staples Dashboard For August
Undercovered Dozen: Elevation Oncology, Ivanhoe Mines, Union Pacific, Golub Capital +